Try our beta test site

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Children's Healthcare of Atlanta
Pediatric Oncology Experimental Therapeutics Investigation Consortium
Information provided by (Responsible Party):
Todd Cooper, Seattle Children's Hospital
ClinicalTrials.gov Identifier:
NCT01319864
First received: March 11, 2011
Last updated: October 17, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)